Helicobacter pyloris and quamous cell carcinoma of esophagus : Case-Control study
Not Applicable
- Conditions
- squamous cell carcinoma of esophagus
- Registration Number
- JPRN-UMIN000002321
- Lead Sponsor
- Gastroenterology Division, Yokohama City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patient who does not written informed consent.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient which was diagnosed is case group. Patient which match to age and sex is control group. We check serum Helicobacter pylori IgG antibody and make a comparative study.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link Helicobacter pylori infection to esophageal squamous cell carcinoma pathogenesis?
How effective is Helicobacter pylori eradication therapy compared to standard-of-care in preventing esophageal squamous cell carcinoma?
Which biomarkers are associated with Helicobacter pylori-related esophageal squamous cell carcinoma risk in case-control studies?
What adverse outcomes are linked to Helicobacter pylori infection in esophageal squamous cell carcinoma patients?
Are there synergistic effects between Helicobacter pylori eradication and other risk factors like smoking in esophageal squamous cell carcinoma prevention?